File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Anti-tumour necrosis factor-α: The dawn of a new era in the treatment of rheumatoid arthritis

TitleAnti-tumour necrosis factor-α: The dawn of a new era in the treatment of rheumatoid arthritis
Authors
Brooks, PKim, HYLau, CS
KeywordsAnkylosing Spondylitis
Clinical Trial
Drug Cost
Drug Dose Regimen
Drug Potentiation
Drug Safety
Editorial
Human
Immune Response
Priority Journal
Remission
Rheumatoid Arthritis
Spondyloarthropathy
Symptom
Tuberculosis
United Kingdom
Issue Date2006
PublisherBlackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/APL
Citation
Aplar Journal Of Rheumatology, 2006, v. 9 n. 2, p. 103-104 How to Cite?
DOI: http://dx.doi.org/10.1111/j.1479-8077.2006.00184.x
Persistent Identifierhttp://hdl.handle.net/10722/91462
ISSN
0219-0494
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorBrooks, Pen_HK
dc.contributor.authorKim, HYen_HK
dc.contributor.authorLau, CSen_HK
dc.date.accessioned2010-09-17T10:19:48Z-
dc.date.available2010-09-17T10:19:48Z-
dc.date.issued2006en_HK
dc.identifier.citationAplar Journal Of Rheumatology, 2006, v. 9 n. 2, p. 103-104en_HK
dc.identifier.issn0219-0494en_HK
dc.identifier.urihttp://hdl.handle.net/10722/91462-
dc.languageengen_HK
dc.publisherBlackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/APLen_HK
dc.relation.ispartofAPLAR Journal of Rheumatologyen_HK
dc.subjectAnkylosing Spondylitisen_HK
dc.subjectClinical Trialen_HK
dc.subjectDrug Costen_HK
dc.subjectDrug Dose Regimenen_HK
dc.subjectDrug Potentiationen_HK
dc.subjectDrug Safetyen_HK
dc.subjectEditorialen_HK
dc.subjectHumanen_HK
dc.subjectImmune Responseen_HK
dc.subjectPriority Journalen_HK
dc.subjectRemissionen_HK
dc.subjectRheumatoid Arthritisen_HK
dc.subjectSpondyloarthropathyen_HK
dc.subjectSymptomen_HK
dc.subjectTuberculosisen_HK
dc.subjectUnited Kingdomen_HK
dc.titleAnti-tumour necrosis factor-α: The dawn of a new era in the treatment of rheumatoid arthritisen_HK
dc.typeArticleen_HK
dc.identifier.emailLau, CS:cslau@hku.hken_HK
dc.identifier.authorityLau, CS=rp01348en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1111/j.1479-8077.2006.00184.xen_HK
dc.identifier.scopuseid_2-s2.0-33745964554en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-33745964554&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume9en_HK
dc.identifier.issue2en_HK
dc.identifier.spage103en_HK
dc.identifier.epage104en_HK
dc.identifier.eissn1479-8077-
dc.publisher.placeAustraliaen_HK
dc.identifier.scopusauthoridBrooks, P=35374555300en_HK
dc.identifier.scopusauthoridKim, HY=24465534700en_HK
dc.identifier.scopusauthoridLau, CS=14035682100en_HK
dc.identifier.issnl0219-0494-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats